Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology

被引:80
作者
Brockow, K [1 ]
Akin, C [1 ]
Huber, M [1 ]
Metcalfe, DD [1 ]
机构
[1] NIAID, NIH, Lab Allerg Dis, Bethesda, MD 20892 USA
关键词
D O I
10.1067/mjd.2003.98
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. Cutaneous involvement occurs in most patients with systemic mastocytosis. Objective: We sought to determine whether the extent of cutaneous involvement is predictive of systemic disease. Methods: In a prospective survey of 48 adults and 19 children, the extent and density of cutaneous lesions were compared with patient history, symptoms, internal organ involvement, serum total mast cell tryptase level, and bone marrow pathology. Results: Cutaneous lesions in children were of a greater mean and maximum diameter, but similar in extent and density compared with lesions in adults. In adults with skin lesions, the extent of lesions correlated to disease duration. Adults with extensive cutaneous disease experienced more pruritus and flushing. Fatigue, splenomegaly, and hepatomegaly were more frequent in adults without cutaneous involvement; and in those with a greater density of lesions and disease duration. Increased tryptase levels were found in children and adults with systemic disease and correlated to skin lesion density and bone marrow pathology. Conclusion: An examination of the extent and density of cutaneous lesions in adults helps identify those with more extensive extracutaneous disease and, thus, requiring a more thorough evaluation. (J Am Acad Dermatol 2003;48:508-16.).
引用
收藏
页码:508 / 516
页数:9
相关论文
共 22 条
[1]   Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology [J].
Akin, C ;
Schwartz, LB ;
Kitoh, T ;
Obayashi, H ;
Worobec, AS ;
Scott, LM ;
Metcalfe, DD .
BLOOD, 2000, 96 (04) :1267-1273
[2]   Regression of urticaria pigmentosa in adult patients with systemic mastocytosis - Correlation with clinical patterns of disease [J].
Brockow, K ;
Scott, LM ;
Worobec, AS ;
Kirshenbaum, A ;
Akin, C ;
Huber, MM ;
Metcalfe, DD .
ARCHIVES OF DERMATOLOGY, 2002, 138 (06) :785-790
[3]   Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: Correlation with dermal mast-cell numbers and mast-cell tryptase [J].
Brockow, K ;
Akin, C ;
Huber, M ;
Scott, LM ;
Schwartz, LB ;
Metcalfe, DD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) :82-88
[4]  
CAPLAN RM, 1965, J AMER MED ASSOC, V194, P1077
[5]   Association of the Q576R polymorphism in the interleukin-4 receptor α chain with indolent mastocytosis limited to the skin [J].
Daley, T ;
Metcalfe, DD ;
Akin, C .
BLOOD, 2001, 98 (03) :880-882
[6]   SYSTEMIC MASTOCYTOSIS - RETROSPECTIVE REVIEW OF A DECADES CLINICAL-EXPERIENCE AT THE BRIGHAM AND WOMENS HOSPITAL [J].
HORAN, RF ;
AUSTEN, KF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (03) :S5-S14
[7]  
Jaffe ES, 2001, WHO CLASSIFICATION T, P293
[8]   Lymphoid tissues and the immune system in mastocytosis [J].
Mekori, YA .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2000, 14 (03) :569-+
[9]  
Metcalfe DD, 1991, J INVEST DERMATOL, V96, p2S, DOI [10.1111/1523-1747.ep12468882., DOI 10.1111/1523-1747.EP12468882]
[10]   MASTOCYTOSIS AND ATOPY - A STUDY OF 33 PATIENTS WITH URTICARIA-PIGMENTOSA [J].
MULLER, U ;
HELBLING, A ;
HUNZIKER, T ;
WUTHRICH, B ;
PECOUD, A ;
GILARDI, S ;
BERETTA, E ;
FASEL, J ;
MESSERLI, W ;
MAURER, P .
ALLERGY, 1990, 45 (08) :597-603